A report led by Chinese experts suggests over 60% of liver cancer cases are preventable. Reducing the annual incidence by 2% could reverse rising cases and deaths by 2050, potentially averting millions of cases and deaths. The report, published in The Lancet, outlines a comprehensive strategy for prevention and treatment.
The report highlights a shift in causes, with MASLD and MASH emerging as major contributors alongside traditional factors like hepatitis B, C, and alcohol. It projects increases in MASH and alcohol-related cases, while hepatitis B and C cases are expected to decline.
The report also showcases successful practices from Qidong, China, Italy, and Egypt. Qidong's proactive measures, including vaccination and screening, improved survival rates. Italy's screening programs and Egypt's national committee for screening and treatment have also proven effective.
The report calls for collaboration among health stakeholders to reduce the global burden of liver cancer and improve patient outcomes.
5 Comments
Katchuka
Qidong's success due to vaccination is not enough to prove this will work everywhere.
BuggaBoom
This sounds more like a marketing strategy than a legitimate health initiative.
Eugene Alta
We need to invest in preventive strategies as outlined in this report—it's a holistic approach to health.
Loubianka
This report seems overly optimistic. How can we trust predictions when so many variables are at play?
KittyKat
I’m impressed with the strategies highlighted from different countries; collaboration is key!